Nomura Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.7M | Sell |
26,101
-21,761
| -45% | -$10.1M | 0.03% | 388 |
|
|
2025
Q4 | $21.7M | Sell |
47,862
-20,392
| -30% | -$8.79M | 0.03% | 301 |
|
|
2025
Q3 | $26.7M | Buy |
68,254
+66,650
| +4,155% | +$27.9M | 0.04% | 251 |
|
|
2025
Q2 | $714K | Sell |
1,604
-3,130
| -66% | -$1.44M | ﹤0.01% | 1070 |
|
|
2025
Q1 | $2.3M | Sell |
4,734
-41,167
| -90% | -$19.2M | ﹤0.01% | 1006 |
|
|
2024
Q4 | $18.5M | Buy |
45,901
+5,868
| +15% | +$2.72M | 0.02% | 361 |
|
|
2024
Q3 | $18.6M | Buy |
40,033
+35,626
| +808% | +$17.1M | 0.04% | 288 |
|
|
2024
Q2 | $2.07M | Sell |
4,407
-389
| -8% | -$169K | ﹤0.01% | 932 |
|
|
2024
Q1 | $2M | Sell |
4,796
-4,174
| -47% | -$1.76M | 0.01% | 904 |
|
|
2023
Q4 | $3.65M | Buy |
+8,970
| New | +$3.31M | 0.01% | 771 |
|
|
2023
Q3 | – | Sell |
-1,164
| Closed | -$410K | – | 1666 |
|
|
2023
Q2 | $410K | Buy |
+1,164
| New | +$392K | ﹤0.01% | 1080 |
|
|
2022
Q3 | – | Sell |
-1,476
| Closed | -$424K | – | 1974 |
|
|
2022
Q2 | $424K | Sell |
1,476
-3,007
| -67% | -$805K | ﹤0.01% | 1154 |
|
|
2022
Q1 | $1.19M | Sell |
4,483
-10,618
| -70% | -$2.52M | ﹤0.01% | 1044 |
|
|
2021
Q4 | $3.32M | Sell |
15,101
-320
| -2% | -$62.2K | 0.01% | 839 |
|
|
2021
Q3 | $2.78M | Sell |
15,421
-1,229
| -7% | -$240K | 0.01% | 818 |
|
|
2021
Q2 | $3.36M | Buy |
16,650
+15,423
| +1,257% | +$3.23M | 0.01% | 695 |
|
|
2021
Q1 | $264K | Sell |
1,227
-16,924
| -93% | -$3.72M | ﹤0.01% | 1552 |
|
|
2020
Q4 | $4.29M | Buy |
18,151
+17,374
| +2,236% | +$3.99M | 0.01% | 618 |
|
|
2020
Q3 | $212K | Sell |
777
-28,814
| -97% | -$7.95M | ﹤0.01% | 1175 |
|
|
2020
Q2 | $8.6M | Sell |
29,591
-51,197
| -63% | -$13.9M | 0.03% | 297 |
|
|
2020
Q1 | $19.2M | Buy |
80,788
+69,415
| +610% | +$15.9M | 0.08% | 136 |
|
|
2019
Q4 | $2.49M | Buy |
+11,373
| New | +$2.3M | 0.01% | 608 |
|
|
2019
Q1 | – | Sell |
-75,015
| Closed | -$12.4M | – | 1421 |
|
|
2018
Q4 | $12.4M | Buy |
+75,015
| New | +$13M | 0.05% | 275 |
|
|
2018
Q3 | – | Sell |
-35,276
| Closed | -$6M | – | 1525 |
|
|
2018
Q2 | $6M | Buy |
35,276
+11,436
| +48% | +$1.77M | 0.02% | 470 |
|
|
2018
Q1 | $3.88K | Sell |
23,840
-61,440
| -72% | -$10M | 0.01% | 632 |
|
|
2017
Q4 | $12.8M | Buy |
85,280
+65,730
| +336% | +$9.73M | 0.02% | 397 |
|
|
2017
Q3 | $2.97M | Sell |
19,550
-5,655
| -22% | -$851K | 0.01% | 722 |
|
|
2017
Q2 | $3.25M | Buy |
25,205
+15,366
| +156% | +$1.85M | 0.01% | 682 |
|
|
2017
Q1 | $1.08M | Sell |
9,839
-24,131
| -71% | -$2.12M | ﹤0.01% | 770 |
|
|
2016
Q4 | $2.55M | Buy |
+33,970
| New | +$2.76M | 0.01% | 788 |
|
|
2016
Q2 | – | Sell |
-3,285
| Closed | -$260K | – | 1646 |
|
|
2016
Q1 | $260K | Buy |
3,285
+1,054
| +47% | +$95.3K | ﹤0.01% | 1116 |
|
|
2015
Q4 | $281K | Sell |
2,231
-108
| -5% | -$13K | ﹤0.01% | 1361 |
|
|
2015
Q3 | $239K | Sell |
2,339
-6,575
| -74% | -$845K | ﹤0.01% | 1310 |
|
|
2015
Q2 | $1.06M | Buy |
8,914
+6,962
| +357% | +$877K | ﹤0.01% | 1026 |
|
|
2015
Q1 | $225K | Sell |
1,952
-17,601
| -90% | -$2.11M | ﹤0.01% | 1466 |
|
|
2014
Q4 | $2.25M | Sell |
19,553
-112,912
| -85% | -$12.7M | 0.01% | 992 |
|
|
2014
Q3 | $14.4M | Buy |
+132,465
| New | +$12.6M | 0.04% | 339 |
|
|
2014
Q2 | – | Sell |
-43,928
| Closed | -$3.11M | – | 3057 |
|
|
2014
Q1 | $3.11M | Buy |
43,928
+29,041
| +195% | +$2.3M | ﹤0.01% | 956 |
|
|
2013
Q4 | $1.1M | Sell |
14,887
-42,075
| -74% | -$2.93M | 0.01% | 950 |
|
|
2013
Q3 | $4.31M | Buy |
56,962
+52,200
| +1,096% | +$4.15M | 0.03% | 528 |
|
|
2013
Q2 | $381K | Buy |
+4,762
| New | +$351K | ﹤0.01% | 1478 |
|
Other funds holding VRTX
VCM
VPM
Nomura Holdings's VRTX Position: Q1 2026 in Review
Nomura Holdings reduced its Vertex Pharmaceuticals (VRTX) stake by 45% in Q1 2026, selling an estimated $10.1M and leaving 26,101 shares worth $11.7M. The position accounts for 0.03% of the portfolio, ranked #388.
Nomura Holdings first reported a position in VRTX in Q2 2013 and has held it in 41 quarters since. The position peaked at $26.7M in Q3 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Nomura Holdings held 26,101 shares of Vertex Pharmaceuticals worth $11.7M as of Q1 2026.
- Nomura Holdings sold 21,761 Vertex Pharmaceuticals shares in Q1 2026, an estimated $10.1M.
- Vertex Pharmaceuticals made up 0.03% of Nomura Holdings's portfolio in Q1 2026, its #388 holding.
- Nomura Holdings first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 41 quarters since.
- Nomura Holdings's Vertex Pharmaceuticals position peaked at $26.7M in Q3 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.